BICARA THERAPEUTICS ($BCAX) posted quarterly earnings results for Q3 2026 on Monday, November 9th. The company reported earnings of -$1.04 per share, missing estimates of -$0.85 by $0.19. The company also reported revenue of $0, equaling estimates of $0 by $0.
You can see Quiver Quantitative's $BCAX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BICARA THERAPEUTICS Insider Trading Activity
BICARA THERAPEUTICS insiders have traded $BCAX stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.
Here’s a breakdown of recent trading of $BCAX stock by insiders over the last 6 months:
- RYAN COHLHEPP (President, COO & Interim CEO) has made 0 purchases and 9 sales selling 77,500 shares for an estimated $2,012,027.
- IVAN HYEP (Chief Financial Officer) has made 0 purchases and 5 sales selling 49,700 shares for an estimated $1,345,146.
- CLAIRE MAZUMDAR (Chief Executive Officer) has made 0 purchases and 5 sales selling 35,000 shares for an estimated $864,526.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
BICARA THERAPEUTICS Hedge Fund Activity
We have seen 89 institutional investors add shares of BICARA THERAPEUTICS stock to their portfolio, and 58 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 6,173,244 shares (+3735.9%) to their portfolio in Q2 2026, for an estimated $183,283,614
- ATLE FUND MANAGEMENT AB removed 1,023,977 shares (-87.5%) from their portfolio in Q2 2026, for an estimated $30,401,877
- JPMORGAN CHASE & CO added 1,015,965 shares (+inf%) to their portfolio in Q2 2026, for an estimated $30,164,000
- BLACKROCK, INC. added 1,004,383 shares (+35.3%) to their portfolio in Q2 2026, for an estimated $29,820,131
- FIL LTD removed 617,730 shares (-90.9%) from their portfolio in Q2 2026, for an estimated $18,340,403
- OMEGA FUND MANAGEMENT, LLC removed 570,000 shares (-23.8%) from their portfolio in Q2 2026, for an estimated $16,923,300
- PRICE T ROWE ASSOCIATES INC /MD/ added 528,050 shares (+38.4%) to their portfolio in Q2 2026, for an estimated $15,677,804
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
